Page last updated: 2024-08-23

phosphotyrosine and Cancer of Head

phosphotyrosine has been researched along with Cancer of Head in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (14.29)18.2507
2000's3 (42.86)29.6817
2010's2 (28.57)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Cao, N; Cha, JH; Chen, Y; Lan, HY; Yan, X; Yang, MH; Yang, WH1
Chen, W; Deng, R; Han, Z; Hanada, S; Liu, Y; Wang, X; Xu, Q; Yan, M; Zhang, J; Zhang, P1
Balaji, SA; Califano, JA; Chatterjee, A; Chavan, S; Gowda, H; Jain, AP; Kumar, MM; Mathur, PP; Nanjappa, V; Pandey, A; Pinto, SM; Prasad, TS; Puttamallesh, VN; Radhakrishnan, A; Raja, R; Rangarajan, A; Sahasrabuddhe, NA; Santosh, V; Sathe, G; Sidransky, D; Sukumar, G1
Gooding, WE; Grandis, JR; Li, M; Lui, VW; Niwa, H; Wentzel, AL1
Fenyo, D; Gibson, N; Griffin, G; Haley, JD; Hunt, T; Iwata, K; Petti, F; Settinari, T; Thelemann, A1
Collins, B; Gooding, WE; Grandis, JR; Handler, PN; Seethala, RR; Siegfried, JM; Zhang, Q1
Arnold, LD; Baker, DA; Barbacci, EG; Davis, JA; Doty, JL; Iwata, KK; Morin, MJ; Moyer, JD; Pollack, VA; Pustilnik, LR; Savage, DM; Sloan, DE; Smolarek, TA; Tsaparikos, KE; Vaidya, MP1

Other Studies

7 other study(ies) available for phosphotyrosine and Cancer of Head

ArticleYear
MT4-MMP promotes invadopodia formation and cell motility in FaDu head and neck cancer cells.
    Biochemical and biophysical research communications, 2020, 02-19, Volume: 522, Issue:4

    Topics: Adaptor Proteins, Vesicular Transport; Cardiac Myosins; cdc42 GTP-Binding Protein; Cell Line, Tumor; Cell Movement; Gelatin; Head and Neck Neoplasms; HEK293 Cells; Humans; Matrix Metalloproteinases, Membrane-Associated; Myosin Light Chains; Neoplasm Invasiveness; Phosphorylation; Phosphotyrosine; Podosomes; Protein Binding; Receptor, Platelet-Derived Growth Factor alpha; rho GTP-Binding Proteins; Signal Transduction; src-Family Kinases

2020
A new gamboge derivative compound 2 inhibits cancer stem-like cells via suppressing EGFR tyrosine phosphorylation in head and neck squamous cell carcinoma.
    Journal of cellular and molecular medicine, 2013, Volume: 17, Issue:11

    Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cisplatin; ErbB Receptors; Female; Head and Neck Neoplasms; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplastic Stem Cells; Phosphorylation; Phosphotyrosine; Protein Kinase Inhibitors; Protein Processing, Post-Translational; Spheroids, Cellular; Tumor Burden; Xanthones; Xenograft Model Antitumor Assays

2013
A dual specificity kinase, DYRK1A, as a potential therapeutic target for head and neck squamous cell carcinoma.
    Scientific reports, 2016, 10-31, Volume: 6

    Topics: Animals; Apoptosis; bcl-X Protein; Carcinoma, Squamous Cell; Caspase 9; Cell Line; Cell Movement; Dyrk Kinases; Female; Forkhead Box Protein O3; Harmine; Head and Neck Neoplasms; Humans; Immunohistochemistry; Mice; Mice, Nude; Phosphorylation; Phosphotyrosine; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-akt; RNA Interference; RNA, Small Interfering; Small Molecule Libraries; Squamous Cell Carcinoma of Head and Neck; Tandem Mass Spectrometry; Tissue Array Analysis; Transplantation, Heterologous

2016
Antitumor effects of epidermal growth factor receptor antisense oligonucleotides in combination with docetaxel in squamous cell carcinoma of the head and neck.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2003, Oct-15, Volume: 9, Issue:13

    Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Blotting, Western; Carcinoma, Squamous Cell; Cell Division; Cell Line, Tumor; Coloring Agents; DNA-Binding Proteins; Docetaxel; Dose-Response Relationship, Drug; Down-Regulation; ErbB Receptors; Female; Head and Neck Neoplasms; Humans; Inhibitory Concentration 50; Mice; Mice, Nude; Neoplasm Transplantation; Oligonucleotides, Antisense; Phosphotyrosine; Signal Transduction; STAT3 Transcription Factor; Taxoids; Tetrazolium Salts; Thiazoles; Time Factors; Trans-Activators; Vascular Endothelial Growth Factor A

2003
Phosphotyrosine signaling networks in epidermal growth factor receptor overexpressing squamous carcinoma cells.
    Molecular & cellular proteomics : MCP, 2005, Volume: 4, Issue:4

    Topics: Carcinoma, Squamous Cell; Cell Adhesion; Cell Line, Tumor; Chromatography, Affinity; Chromatography, Liquid; Enzyme Activation; ErbB Receptors; Erlotinib Hydrochloride; Head and Neck Neoplasms; Humans; Immunoblotting; Isotopes; Mass Spectrometry; Models, Biological; Peptide Mapping; Phosphorylation; Phosphotyrosine; Proteins; Quinazolines; Signal Transduction; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; src-Family Kinases

2005
Immunohistochemical analysis of phosphotyrosine signal transducer and activator of transcription 3 and epidermal growth factor receptor autocrine signaling pathways in head and neck cancers and metastatic lymph nodes.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2008, Mar-01, Volume: 14, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Cohort Studies; ErbB Receptors; Female; Head and Neck Neoplasms; Humans; Immunoenzyme Techniques; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Phosphotyrosine; Receptors, Bombesin; Signal Transduction; STAT3 Transcription Factor; Transcriptional Activation; Transforming Growth Factor alpha

2008
Inhibition of epidermal growth factor receptor-associated tyrosine phosphorylation in human carcinomas with CP-358,774: dynamics of receptor inhibition in situ and antitumor effects in athymic mice.
    The Journal of pharmacology and experimental therapeutics, 1999, Volume: 291, Issue:2

    Topics: Animals; Antineoplastic Agents; Body Weight; Cell Division; Cisplatin; Dose-Response Relationship, Drug; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; ErbB Receptors; Erlotinib Hydrochloride; Female; Head and Neck Neoplasms; Humans; Mice; Mice, Nude; Phosphorylation; Phosphotyrosine; Polypharmacy; Quinazolines; Time Factors; Transplantation, Heterologous; Tumor Cells, Cultured; Tyrosine

1999